European Heart Journal·29 AugESC Guidelines on prevention and rehabilitation in coronary heart disease and current practice: the EUROASPIRE VI surveyCohort study of 8,590 peopleCoronary heart diseasePaper
The British Journal of Cardiology·8 AugReal-world efficacy of inclisiran: data from a tertiary lipid clinicCohort study of 238 peopleInclisiranPaper
American Heart Journal·8 AugHPS-4/TIMI 65/ORION-4: A double-blind randomized placebo-controlled trial assessing the effects of inclisiran on clinical outcomes among people with atherosclerotic cardiovascular disease: Trial design, recruitment, and baseline characteristicsTrial in peopleInterventionsPaper
AHA Scientific Sessions 2025 Abstract·3 NovCholesteryl Ester Transfer Protein (CETP) Inhibition with Obicetrapib Produces Substantial Reductions in LDL Particles: Pooled Analysis of BROOKLYN and BROADWAY Phase 3 Clinical TrialsTrial in peopleInterventionsPaper